To assess if the ligand Gas6 or its TAM receptors are differentially expressed within tumors in comparison to normal intestinal mucosa of the same patients, we performed qPCRs from 200 primary tumors with different tumor stages (UICC stage I–IV). Here, GAS6 is linked to neoplasm.